StockData
Cabaletta Bio, Inc. logo

Cabaletta Bio, Inc. (CABA) income statement

CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30
$1.05+0.03 (+3.43%)

Close on Nov 18, 2026Market cap $178.87MP/E –Yield –

See a number that looks wrong?